IDO1 and major depressive disorder: In conclusion, this study showed changes in the diversity and relative abundance of the gut microbiota in MDD patients, as well as elevated Ido and Kyn concentrations indicative of Kyn pathway activation, which may be utilized as biomarkers of MDD.